Neurotoxin Market Size Report – Growth & Outlook 2028
[研究报告] 神经毒素市场规模预计将从 2022 年的 66.2236 亿美元增至 2028 年的 131.9506 亿美元;预计 2023 年至 2028 年的复合年增长率为 12.3%。
神经毒素被广泛用作治疗物质或治疗各种疾病的药剂。它广泛用于 面部美容和治疗肌肉运动等。神经毒素的内化和细胞质蛋白水解酶传递特性有助于切割神经递质胞吐不可或缺的蛋白质,可用于治疗疾病。市场的增长主要由几个关键驱动因素推动,例如改善外观的整容手术激增以及创新面部美容产品的出现。然而,在预测期内,不适当/不恰当的注射技术阻碍了市场的增长。
神经毒素市场根据产品类型、应用、最终用户和地理位置进行细分。按地理位置划分,市场大致分为北美、欧洲、亚太地区、中东、非洲和南美及中美洲。该报告提供了对市场的深入分析和见解,强调了市场趋势、技术进步和市场动态等参数,以及全球主要市场参与者的竞争格局分析。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
神经毒素市场:
Neurotoxin Market: Strategic Insights
Neurotoxin Market
-
CAGR (2022 - 2028)
12.3%
-
Market Size 2022
US$ 6.62 Billion
-
Market Size 2028
US$ 13.2 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Merz Pharma GmbH Co KGaA
- AbbVie Inc
- Revance Therapeutics Inc
- Ipsen SA
- List Biological Labs Inc
- Medytox Inc
- Evolus Inc
- Hugel Inc
- Lanzhou Institute of Biological Products Co Ltd
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
产品类型(Botox、Dysport、Xeomin 等)
应用(治疗和美容)
最终用户(医院、专科诊所、皮肤科诊所等)
Neurotoxin Market: Strategic Insights
-
CAGR (2022 - 2028)12.3% -
Market Size 2022
US$ 6.62 Billion -
Market Size 2028
US$ 13.2 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Merz Pharma GmbH Co KGaA
- AbbVie Inc
- Revance Therapeutics Inc
- Ipsen SA
- List Biological Labs Inc
- Medytox Inc
- Evolus Inc
- Hugel Inc
- Lanzhou Institute of Biological Products Co Ltd
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2022 - 2028)12.3%- 2022 年市场规模
66.2 亿美元 - 2028 年市场规模
132 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 梅尔茨制药有限公司
- 艾伯维公司
- Revance治疗公司
- 益普生公司
- 利斯特生物实验室有限公司
- Medytox公司
- Evolus 公司
- 休格尔公司
- 兰州生物制品研究所有限公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 肉毒杆菌
- 保妥适
- 西奥明
- 其他的
- 治疗和美容
- 医院
- 专科诊所
- 皮肤科诊所
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场洞察 – 神经毒素市场
改善外貌的整容手术激增
随着年龄增长,细胞功能下降,皮肤、肌肉、韧带、脂肪和骨骼的结构变化在人的脸上变得明显。许多人通常不积极看待不可避免的衰老生理过程,这反过来又促使他们沉迷于美容嫩肤手术以保持年轻的外表。肉毒杆菌毒素(BOTA) 是由肉毒梭菌自然产生的,是全球美容手术中最常用的神经毒素。美国整形外科协会透露,2019 年注射了超过 740 万剂 A 型 BOTA,证明它是全球最受推荐的微创美容手术。
以下案例研究进一步说明了使用 BOTA 来改善外观:
案件标题:
BOTA 面部护理
挑战:
一名 74 岁的男性患者寻求通过手术减少面部皱纹的指导
结果与讨论:
肉毒杆菌毒素 A (BOTA) 的应用针对眼眶区域和鼻部区域,以减少面部上三分之一的动态皱纹。在四个部位各注射了两个单位。每只眼睛的眼眶肌肉均接受了 10 个单位的 BOTA 注射,均匀分布在五个部位。为了使患者的眼睛看起来更宽,并帮助矫正眉毛下垂,在眉弓方向向每只眼睛的眼眶肌肉注射了 1 个单位的 BOTA。总共使用了 58 个单位的 BOTA,均匀分布在面部上三分之一的肌肉上,以增强眉弓,减少动态皱纹,促进面部年轻化。
治疗上述病例的 BOTA 选择含有 500 欧洲单位的 Abobotulinum A (ABO; Dysport/Ipsen Limited, Slough Berkshire, UK)。按照制造商推荐的比例(2.5 毫升生理盐水与 500 单位肉毒杆菌毒素)注射,然后进行配制。
因此,BOTA 已被证明可以有效改变眉毛位置,并使面部上部三分之一恢复年轻。因此,使用神经毒素减少面部皱纹,同时确保安全、有效和高效的美容手术越来越受欢迎,这催化了神经毒素市场的发展。
应用程序洞察
根据应用,全球神经毒素市场细分为治疗和美容。治疗领域在 2022 年占据了更大的市场份额。预计美容领域在预测期内的复合年增长率会更高。神经毒素具有广泛的医疗条件,可治疗慢性偏头痛、成人痉挛、儿童痉挛等疾病。上述临床适应症可在患者中暂时用神经毒素治疗。对于偏头痛,BOTOX onabotulinumtoxin A 是一种注射到肌肉中的处方药,具有预防成人慢性偏头痛头痛的临床效果。此外,对于成人痉挛,BOTOX(onabotulinumtoxinA)是一种注射到肌肉中的处方药,用于治疗 2 岁及以上患有痉挛的人的肌肉僵硬增加。肉毒杆菌注射治疗慢性偏头痛和其他临床效果所提供的这种临床效果是显着的分段增长的原因,从而在 2022-2028 年期间主导整体神经毒素市场的增长。
公司正在投资开发新的创新产品,以确保通过推出新产品获得良好的投资回报 (ROI)。此外,监管机构的产品批准证实了产品效果的保证。最近,各种市场参与者推出了有效的神经毒素并采取了收购策略。以下列出了市场参与者的一些策略:
- 2023 年 2 月,Evolus, Inc. 宣布在德国和奥地利推出 Nuceiva(A 型肉毒杆菌毒素)。欧盟委员会批准 Nuceiva 用于暂时改善眉间中度至重度垂直纹路(眉间纹),当上述面部纹路的严重程度对 65 岁以下的成年人有重要的心理影响时,这种纹路在皱眉时会出现。
- 2022 年 12 月,Gufic Biosciences 在印度推出了本地开发的 A 型肉毒杆菌毒素 (Botox) 注射剂。Gufic 的肉毒杆菌毒素将在印度以“Zarbot”品牌销售。Zarbot 是与美国 Prime Bio 合作开发和制造的。“Zarbot”采用纯化的 HALL 菌株和专有技术制造,与其他公司相比,其薄膜配方更薄,稳定性更好。
- 2021年8月,Merz Therapeutics公司获得欧盟批准使用XEOMIN对因神经系统/神经发育障碍导致的慢性流涎症的2至17岁、体重12公斤的儿童和青少年进行对症治疗。
- 2023 年 1 月,Hugel America, Inc. 宣布 Croma-Pharma 在欧洲成功完成 Letybo(LetibotulinumtoxinA 注射液)的分散化程序。该批准得到了三项已完成的随机、安慰剂对照 III 期试验的积极结果的支持,这些试验在美国和欧洲招募了 1,000 多名受试者。
这些最新发展是为了提高世界各地人们的美感。此外,治疗应用还能够治愈医学疾病。因此,公司的巨大发展促进了神经毒素市场的增长。
神经毒素市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 66.2亿美元 |
2028 年市场规模 | 132亿美元 |
全球复合年增长率(2022 - 2028) | 12.3% |
历史数据 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
神经毒素 – 市场细分
全球神经毒素市场根据产品类型、应用和最终用户进行细分。根据产品类型,市场分为 Botox、Dysport、Xeomin 等。Botox 细分市场在 2022 年占据最大市场份额,预计在预测期内将实现最高复合年增长率。根据应用,全球神经毒素市场分为治疗和美容。根据最终用户,市场分为医院、皮肤科诊所、医疗水疗中心等。
根据地理位置,神经毒素市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙、波兰、俄罗斯和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚、韩国和亚太其他地区)、中东(阿联酋、沙特阿拉伯、南非、以色列、黎巴嫩和中东其他地区)以及南美洲和中美洲(巴西、阿根廷、委内瑞拉和南美洲和中美洲其他地区)。
公司简介 – 神经毒素市场
- 梅尔茨制药有限公司
- 艾伯维公司
- Revance治疗公司
- 益普生公司
- Medytox公司
- Evolus 公司
- 休格尔公司
- 兰州生物制品研究所有限公司
- 古菲克
- Metabiologics 公司
Neurotoxin Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 6.62 Billion |
Market Size by | US$ 13.2 Billion |
Global CAGR | 12.3% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品类型(Botox、Dysport、Xeomin 等) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors that are driving the growth of market are growth are surge in cosmetic procedures to improve appearance and emergence of innovative facial aesthetic products. However, improper/inappropriate injection technique is anticipated to hinder the growth of market during the forecast period.
Neurotoxin is widely used as a therapeutic substance or an agent to treat various conditions. It is widely used for facial aesthetic and treating muscular movements and others. The internalization and cytosolic delivery of proteolytic enzymes property of neurotoxin that helps in slicing proteins integral to the exocytosis of neurotransmitters allow in treating medical conditions.
The neurotoxin market is analyzed in the basis of product type, application, and end use. Based on product type, is segmented into Botox, Dysport, Xemoin, and others. The Botox segment held the largest share of the neurotoxin market size, and it is anticipated to register the highest CAGR.
The neurotoxin market majorly consists of the players such as Merz Pharma GmbH & Co KGaA, AbbVie Inc, Revance Therapeutics Inc, Ipsen SA, Medytox Inc, Evolus Inc, Hugel Inc, Lanzhou Institute of Biological Products Co Ltd, Gufic, and Metabiologics, Inc.
The List of Companies - Neurotoxin Market
- Merz Pharma GmbH & Co KGaA
- AbbVie Inc
- Revance Therapeutics Inc
- Ipsen SA
- List Biological Labs Inc
- Medytox Inc
- Evolus Inc
- Hugel Inc
- Lanzhou Institute of Biological Products Co Ltd
- Supernus Pharmaceuticals
- Gufic
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.